A real-world study of symptomatic eosinophilia in moderate-to-severe asthma patients on dupilumab therapy

3Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

References Powered by Scopus

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

1448Citations
N/AReaders
Get full text

Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis

131Citations
N/AReaders
Get full text

Effectiveness and safety of dupilumab for the treatment of severe asthma in a real-life French multi-centre adult cohort

102Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Eosinophilia and Adverse Effects of Dupilumab for Respiratory Indications: A Real-World Setting

1Citations
N/AReaders
Get full text

Real-World and Patient-Reported Outcomes of Dupilumab and Other Biological Drugs for Chronic Obstructive Pulmonary Disease—A Systematic Review

1Citations
N/AReaders
Get full text

Dupilumab-related eosinophilia in patients with severe asthma: Post-marketing surveillance in Japan

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Fisch, M., Fajt, M. L., Wenzel, S. E., & Petrov, A. A. (2024). A real-world study of symptomatic eosinophilia in moderate-to-severe asthma patients on dupilumab therapy. Journal of Allergy and Clinical Immunology: In Practice, 12(8), 2183–2186. https://doi.org/10.1016/j.jaip.2024.04.041

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 1

100%

Readers' Discipline

Tooltip

Medicine and Dentistry 1

100%

Save time finding and organizing research with Mendeley

Sign up for free